Table 1.
Baseline characteristics of patients by fasting blood glucose level
| Fasting blood glucose (mg/dL) | |||||
|---|---|---|---|---|---|
| <91 | 91–101 | >101 | diabetic | P-value | |
| Age | 62.43±10.23 | 60.46±11.74 | 64.43±9.05 | 62.80±9.94 | 0.056 |
| Gender | |||||
| Male | 66 (62.3) | 66 (57.4) | 62 (67.4) | 47 (63.5) | 0.522 |
| Female | 40 (37.7) | 49 (42.6) | 30 (32.6) | 27 (36.5) | |
| Smoking status | |||||
| Never | 49 (46.2) | 63 (54.8) | 40 (43.5) | 31 (41.9) | 0.124 |
| Former | 26 (24.5) | 22 (19.1) | 27 (29.3) | 27 (36.5) | |
| Current | 31 (29.3) | 30 (26.1) | 25 (27.2) | 16 (21.6) | |
| Tumor type | |||||
| AC | 70 (66.0) | 81 (70.4) | 64 (69.6) | 44 (59.5) | 0.773 |
| SCC | 29 (27.4) | 23 (20.0) | 21 (22.8) | 23 (31.1) | |
| Other | 7 (6.6) | 11 (9.6) | 7 (7.6) | 7 (9.5) | |
| Cancer stage | |||||
| Stage I/II/III | 39 (36.8) | 50 (43.5) | 39 (42.4) | 30 (40.5) | 0.458 |
| Stage IV | 64 (60.4) | 60 (52.2) | 52 (56.5) | 39 (52.7) | |
| Unknown | 3 (2.8) | 5 (4.3) | 1 (1.1) | 5 (6.8) | |
| Treatment | |||||
| Surgery | 38 (35.9) | 60 (52.1) | 39 (42.4) | 32 (43.2) | 0.697 |
| Other therapy | 53 (50.0) | 47 (40.9) | 44 (47.8) | 34 (46.0) | |
| None | 15 (14.1) | 8 (7.0) | 9 (9.8) | 8 (10.8) | |
| Albumin | |||||
| <35 g/L | 21 (19.8) | 13 (11.3) | 4 (4.4) | 16 (21.6) | 0.462 |
| ≥35 g/L | 85 (80.2) | 102 (88.7) | 88 (95.6) | 58 (78.4) | |
| BMI | |||||
| <18.5 | 16 (15.1) | 12 (10.4) | 6 (6.5) | 3 (4.0) | 0.007 |
| 18.5–23.9 | 65 (81.3) | 71 (61.7) | 52 (56.5) | 49 (66.2) | |
| 24.0–27.9 | 17 (16.0) | 24 (20.9) | 30 (32.6) | 19 (25.7) | |
| ≥28.0 | 8 (7.6) | 8 (7.0) | 4 (4.4) | 3 (4.1) | |
Abbreviations: AC, adenocarcinoma; BMI, body mass index; SCC, squamous cell carcinoma.